Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomecompanyHigh quality API raw material 99% API Candesartan Cilexetil, CAS 145040-37-5
Candesartan cilexetil
Candesartan cilexetil
Candesartan cilexetil
Candesartan cilexetil
Candesartan cilexetil

High quality API raw material 99% API Candesartan Cilexetil, CAS 145040-37-5

Price Get Latest Price
Packge 1g/Bag1Kg/Bag5g/Bag5Kg/Bag25g/Bag25Kg/Drum
  • Min. Order:10g
  • Supply Ability:300kg/month
  • Time:2021-04-08

Product Details

  • Product NameCandesartan cilexetil
  • CAS No.145040-37-5
  • EINECS No.627-030-2
  • MFC33H34N6O6
  • MW610.66
  • Appearancepowderwhite to beige
  • Melting point 168-170?C
  • storage temp. 2-8°C
  • Boiling point 843.3±75.0 °C(Predicted)
  • density 1.37±0.1 g/cm3(Predicted)

Candesartan cilexetil CAS 145040-37-5


Description:

Product Name:

Candesartan cilexetil

Synonyms:

1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate

CAS RN.:

145040-37-5

EINECS:Add
Molecular Weight:610.66
Molecular Formula:C33H34N6O6
refractive_index:1.665


Company Profile Introduction

Pharmahands (Taizhou) Co., Ltd. is a high-tech company based in CMC Taizhou Jiangsu China, focusing on pharmaceutical APIs, cosmetic ingredients and intermediates R&D and manufacture.

Founded in 2012, Pharmahands has established an innovative, cohesive talents group, also built the state-of-the-art laboratories, pilot plants and manufacturing facilities. To meet the demands and expectations of our clients, an advanced QC & QA team was set up.  

We devotes to providing high quality production and professional service, as well as developing with our clients. Our business philosophy is cooperation, honesty, sharing and double-win.

  • Since:2012-02-06
  • Address: A-400, Shuju Building,No. 799, Yaocheng Avenue, CMC, Taizhou City
INQUIRY